Article metrics

Download PDFPDF
Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ

 

Online download statistics by month:

Online download statistics by month: September 2012 to July 2021

AbstractFullPdf
Sep 20123433531
Oct 20121582311
Nov 20123574934
Dec 20123561121
Jan 20131981621
Feb 20139976
Mar 2013861813
Apr 201353185
May 201336105
Jun 20132624
Jul 20135654
Aug 201324206
Sep 20132235
Oct 201338910
Nov 20133078
Dec 20132301
Jan 20141442
Feb 201413311
Mar 201427511
Apr 20142722
May 20143431
Jun 20142645
Jul 20143235
Aug 20142024
Sep 20141345
Oct 20142044
Nov 20141731
Dec 20141243
Jan 20152044
Feb 2015621
Mar 20151232
Apr 20151723
May 2015874
Jun 2015911
Jul 20151100
Aug 2015943
Sep 20152043
Oct 20151200
Nov 20152143
Dec 20152252
Jan 20163523
Feb 20161821
Mar 2016621
Apr 20161022
May 20161233
Jun 201620109
Jul 20161713
Aug 20161163
Sep 20163355
Oct 20162000
Nov 201614117
Dec 20161935
Jan 20172321
Feb 20172010
Mar 20172520
Apr 20172553
May 20171723
Jun 20176165
Jul 20173400
Aug 20172023
Sep 201740410
Oct 20177071
Nov 20172331
Dec 20172421
Jan 20183522
Feb 20183331
Mar 20182900
Apr 20182731
May 20184231
Jun 20182611
Jul 20182422
Aug 20184232
Sep 20183100
Oct 20185620
Nov 20185911
Dec 20184310
Jan 20193700
Feb 20194100
Mar 20194222
Apr 20193910
May 20192111
Jun 20193951
Jul 20194334
Aug 20191710
Sep 20193621
Oct 20195221
Nov 20192911
Dec 20193821
Jan 20204160
Feb 20202533
Mar 20201954
Apr 20202811
May 20201500
Jun 20203000
Jul 20202511
Aug 2020800
Sep 20202000
Oct 20203010
Nov 20201210
Dec 2020800
Jan 20211910
Feb 20212110
Mar 20214142
Apr 20211020
May 20211120
Jun 2021112
Jul 2021100
Total4170463371